HomeBest options strategy › ALEC

Best Options Strategy for ALEC

By Yojana Mandon · Updated 2026 · 2 min read · Risk disclaimer

Looking for the best options strategy for Alector, Inc. (ALEC)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live ALEC option chain right now, and a simple map from your view on ALEC to the strategy that fits it. Model any of them in the calculator before you trade.

About ALEC

Alector, Inc. (ALEC) is a major company in Biotechnology. Options traders on ALEC tend to watch , since these can drive large moves in the share price.

About Alector, Inc.

Alector, Inc. is a clinical-stage biotech firm focused on developing treatments for neurodegenerative diseases in the U.S. market. The company's most advanced candidate, Nivisnebart, is a monoclonal antibody currently in clinical testing for multiple neurodegenerative conditions. Beyond that, Alector has a roster of earlier-stage programs: AL137 targets Alzheimer's disease through anti-amyloid beta activity; AL050 is an enzyme replacement approach designed for Parkinson's disease and Lewy body dementia in patients with specific genetic mutations; and several preclinical candidates using RNA interference technology, including programs against tau and alpha-synuclein pathology. Notably, the company partners with GlaxoSmithKline on developing progranulin-elevating antibodies, a collaboration that includes both Latozinemab and Nivisnebart.

Revenue generation remains limited given the company's early development stage. Alector operates primarily through research funding, partnerships, and milestone payments from collaborations rather than product sales. The partnership with GlaxoSmithKline likely provides capital and development support for shared candidates, though the bulk of…

Today's top-scoring strategy for ALEC

Our engine ranks defined-risk strategies on the live ALEC chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.

Long Call Butterfly neutral
Price: $100.00Implied volatility: 32%Expiration: 2026-07-17 (30d)
ActionQtyTypeStrikePremium
BuyCALL$95$6.83
SellCALL$100$3.82
BuyCALL$105$1.87
P/L at expiry vs today At expiry Today ±1σ
$82$100$118
Max Profit
$394
Max Loss
−$106
Net Debit (cost)
$106
Prob. of Profit
33%
Breakeven(s)
$96.06, $103.94
Implied Vol (ATM)
32%
Position Greeks
Δ
0.43
Γ
−1.202
Θ
1.69
ν
−3.16
Time decay (price held)

Simulation

Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.

Win rate
33%
Mean P/L
−$2
Median
−$106
Exp. move (1σ)
9%
5th pct
−$106
25th pct
−$106
75th pct
$96
95th pct
$333
$-100$144$388
Analyze ALEC in the calculator → Share this pick ↗

Illustrative example at ALEC's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.

Implied volatility

ALEC typically trades with moderate implied volatility, broadly in line with other large-cap stocks. Implied volatility drives option prices, so it is worth checking the live chain before you trade.

Key figures

Market cap
$229M
Beta (vs market)
0.59
52-week range
$1.09–$3.40
Short interest
5.0% of float · 7.0 days to cover

How to choose an options strategy for ALEC

Start with your outlook on ALEC, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:

Bullish

You expect ALEC to rise

Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.

Long Call → Bull Call Spread →

Bearish

You expect ALEC to fall

Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.

Long Put → Bear Put Spread →

Neutral

You expect ALEC to trade in a range

Sell an iron condor to collect premium while ALEC stays between two strikes, or write a covered call against shares you already own.

Iron Condor → Covered Call →

How we pick the best strategy

For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →

Open ALEC in the free calculator →

Frequently asked questions

What is the best options strategy for ALEC?

It depends on your outlook. Bullish traders often use a long call or bull call spread on ALEC; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.

Are ALEC options liquid enough to trade?

Alector, Inc. (ALEC) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.

How much money do I need to trade ALEC options?

Buying a single ALEC call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.

Is this financial advice?

No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade ALEC or any security. Do your own research.

What does Alector, Inc. do?

Alector, Inc. (ALEC) operates in the Biotechnology industry. The "About Alector, Inc." section above gives a fuller picture of what the company does and how it earns money.

Does Alector, Inc. pay a dividend?

Alector, Inc. does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.

Tickers related to ALEC

Comparing ALEC with similar names can help you choose the best options strategy:

GOSSGossamer Bio, Inc.STOKStoke Therapeutics, Inc.DNLIDenali Therapeutics Inc.BDTXBlack Diamond Therapeutics, Inc.

Company information

Headquarters
131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, 94080, United States
Industry
Biotechnology
Employees
103
CEO
Dr. Arnon Rosenthal Ph.D.
Phone
415 231 5660
Website
www.alector.com

Best Options Strategy by Ticker →

Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.